Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR.

Oncologist. 2003;8(1):35-44. Review.

2.

The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.

Posner MR, Colevas AD, Tishler RB.

Semin Oncol. 2000 Aug;27(4 Suppl 8):13-24. Review.

PMID:
10952434
3.

Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN).

Kies MS.

Curr Treat Options Oncol. 2007 Jun;8(3):252-60. Review.

PMID:
17952388
4.

Taxanes in the treatment of head and neck cancer.

Schrijvers D, Vermorken JB.

Curr Opin Oncol. 2005 May;17(3):218-24. Review.

PMID:
15818164
5.

[Recent regimen of chemotherapy for advanced head and neck carcinomas].

Tsukuda M.

Gan To Kagaku Ryoho. 2000 Mar;27(3):341-7. Review. Japanese.

PMID:
10740626
6.

Induction chemotherapy for head and neck cancer: recent data.

Vokes EE.

Oncologist. 2010;15 Suppl 3:3-7. doi: 10.1634/theoncologist.2010-S3-03. Review.

7.

[Docetaxel and squamous cell carcinoma of the head and neck].

Calais G.

Bull Cancer. 2004 Feb;91(2):167-71. Review. French.

PMID:
15047456
8.

Docetaxel in the management of patients with head and neck squamous cell carcinoma.

Bernier J, Vrieling C.

Expert Rev Anticancer Ther. 2008 Jul;8(7):1023-32. doi: 10.1586/14737140.8.7.1023. Review.

PMID:
18588449
9.

TPF sequential therapy: when and for whom?

Budach V.

Oncologist. 2010;15 Suppl 3:13-8. doi: 10.1634/theoncologist.2010-S3-13. Review.

10.

Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

Specenier PM, Vermorken JB.

Cancer Lett. 2007 Oct 28;256(2):166-77. Epub 2007 Jul 27. Review.

PMID:
17673364
11.

[The role of taxanes for head and neck cancer].

Kohno N.

Gan To Kagaku Ryoho. 2005 Dec;32(13):2035-9. Review. Japanese.

PMID:
16352925
12.

Chemotherapy advances in head and neck oncology.

Liggett W Jr, Forastiere AA.

Semin Surg Oncol. 1995 May-Jun;11(3):265-71. Review.

PMID:
7638514
14.

[Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].

Horiuchi M, Tamura Y, Miyake H.

Gan To Kagaku Ryoho. 1994 Mar;21(4):417-24. Review. Japanese.

PMID:
8129381
15.

TPF: a rational choice for larynx preservation?

Calais G.

Oncologist. 2010;15 Suppl 3:19-24. doi: 10.1634/theoncologist.2010-S3-19. Review.

16.

[Chemotherapy of head and neck cancer].

Kohno N, Nakazawa E, Kusunoki M, Nishiya M.

Gan To Kagaku Ryoho. 1996 Feb;23(3):277-82. Review. Japanese.

PMID:
8712819
17.

Docetaxel in squamous cell cancer of the head and neck.

Posner MR.

Anticancer Drugs. 2001 Feb;12 Suppl 1:S21-4. Review.

PMID:
11340900
19.
20.

Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer.

Posner M, Vermorken JB.

Semin Oncol. 2008 Jun;35(3):221-8. doi: 10.1053/j.seminoncol.2008.03.007. Review.

PMID:
18544437
Items per page

Supplemental Content

Write to the Help Desk